We've noticed that you're using an ad blocker

Our content is brought to you free of charge because of the support of our advertisers. To continue enjoying our content, please turn off your ad blocker.

It's off now Dismiss How do I disable my ad blocker?
❌

How to disable your ad blocker for our site:

Adblock / Adblock Plus
  • Click on the AdBlock / AdBlock Plus icon on the top right of your browser.
  • Click “Don’t run on pages on this domain.” OR “Enabled on this site.”
  • Close this help box and click "It's off now".
Firefox Tracking Prevention
  • If you are Private Browsing in Firefox, "Tracking Protection" may casue the adblock notice to show. It can be temporarily disabled by clicking the "shield" icon in the address bar.
  • Close this help box and click "It's off now".
Ghostery
  • Click the Ghostery icon on your browser.
  • In Ghostery versions < 6.0 click “Whitelist site.” in version 6.0 click “Trust site.”
  • Close this help box and click "It's off now".
uBlock / uBlock Origin
  • Click the uBlock / uBlock Origin icon on your browser.
  • Click the “power” button in the menu that appears to whitelist the current website
  • Close this help box and click "It's off now".
  • Topics
  • Refractive
  • Cataract
  • Glaucoma
  • Cornea
  • Practice Management

Modern Medicine Network
  • Login
  • Register
Skip to main content
Modern Medicine Network
  • Login
  • Register
Menu
User
Home
  • Topics
  • Refractive
  • Cataract
  • Glaucoma
  • Cornea
  • Practice Management

SUBSCRIBE: Print / Digital / eNewsletter

Intracameral antibiotics are a win for cataract surgery prophylaxis

Nov 22, 2017
  • Modern Medicine Feature Articles, Modern Medicine Feature Articles, Modern Medicine News, Ophthalmology, Understanding Antibiotic Resistance, Cataract



 

By Vanessa Caceres; Reviewed by Francis Mah, MD

Intracameral antibiotics for prophylaxis during cataract surgery are a safe and effective option compared with a topical or transzonular approach, said Francis S. Mah, MD.

“It’s a timely topic,” said Dr. Mah, director of cornea and external diseases; co-director of refractive surgery, Scripps Health, La Jolla, CA. “Right now, there’s a lot of discussion about drug delivery, compliance, and drug costs. A lot of surgeons are looking for better options.”

Counterpoint: Transzonular approach to antibiotic delivery during cataract surgery is preferable

The interest in intracameral antibiotics as prophylaxis against infection began with the first published studies in the early 1990s by Per Montan, in Europe, Dr. Mah said. “Over time, they’ve gained in momentum,” he said. “There is study after study proving their efficacy, including large studies in the United States showing that intracameral antibiotics are superior to what we have historically done, which is use a topical approach.”

 

 

Many efficacy studies

Dr. Mah pointed out that there are many studies showing that intracameral antibiotics are superior to topicals in terms of efficacy. “In addition, intracameral antibiotics are a clear solution at the conclusion of surgery,” he added. “Therefore, patients can see just as well as after conventional surgery.”

Another advantage is that there is no learning curve with intracameral administration for cataract surgeons. Dr. Mah contrasted intracameral antibiotics with the newer transzonular approach.

“Right now, the transzonular approach is a wait-and-see,” Dr. Mah said. “It’s another interesting way of administering drugs to the eye, improving compliance, and possibly lessening endophthalmitis risk, but the jury is still out in saying it’s superior to topicals or intracamerals.”

 

 

Clouded vision

Dr. Mah also argued that a transzonular approach includes a suspension steroid that can potentially cloud the vision for days to weeks, and it has the potential for changing the effective lens position (ELP). “There are some case reports on the ELP changing because of the medications being placed into the anterior vitreous,” he said.

Ultimately, intracameral antibiotics improve efficacy and the patient experience by reducing their cost and instructions. They also help surgeons have confidence that they are using the most effective means of infection prevention, without relying on patient compliance, Dr. Mah concluded.

“Everyone is in the same boat of trying to improve the patient experience, reduce overall health care expense, and yet improve outcomes,” he said.

Francis S. Mah, MD

p. 585-554-7996

e: [email protected]

This article is adapted from a presentation that Dr. Mah delivered at the 2017 American Society of Cataract and Refractive Surgery. Dr. Mah has financial interests with Allergan, Bausch & Lomb, Novartis, Ocular Science, and PolyActiva.

Related Articles

  • Drug delivery systems could improve poor adherence
  • Five secrets to success with co-management
  • Trying new things in medicine
  • MACRA changes are part of volume-to-value shift
  • Lessons learned from Shake Shack and Danny Meyer

Resource Topics rightRail

  • Resource Topics
  • Partner Content
  • Therapeutic Glaucoma
  • IOL
There is currently no available content. Please check back soon.
  • Twitter
  • Facebook
  • Google_plus
  • Rss
Modern Medicine Network
  • Column 1
    • Home
    • About Us
  • Column 2
    • Advertise
    • Advertiser Terms
  • Column 3
    • Privacy Statement
    • Terms & Conditions
  • Column 4
    • Editorial & Advertising Policy
    • Contact Us
Modern Medicine Network
© UBM 2018, All rights reserved.
Reproduction in whole or in part is prohibited.